These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 17382834

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M, Massberg S, Laugwitz KL, Dirschinger J, Schömig A, LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators.
    J Am Coll Cardiol; 2009 May 12; 53(19):1760-8. PubMed ID: 19422982
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
    Kim YH, Dangas GD, Solinas E, Aoki J, Parise H, Kimura M, Franklin-Bond T, Dasgupta NK, Kirtane AJ, Moussa I, Lansky AJ, Collins M, Stone GW, Leon MB, Moses JW, Mehran R.
    Am J Cardiol; 2008 Mar 15; 101(6):801-6. PubMed ID: 18328844
    [Abstract] [Full Text] [Related]

  • 4. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Park SW, Park SJ.
    J Am Coll Cardiol; 2009 Aug 25; 54(9):853-9. PubMed ID: 19695467
    [Abstract] [Full Text] [Related]

  • 5. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry.
    Chieffo A, Park SJ, Valgimigli M, Kim YH, Daemen J, Sheiban I, Truffa A, Montorfano M, Airoldi F, Sangiorgi G, Carlino M, Michev I, Lee CW, Hong MK, Park SW, Moretti C, Bonizzoni E, Rogacka R, Serruys PW, Colombo A.
    Circulation; 2007 Jul 10; 116(2):158-62. PubMed ID: 17576862
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A, Brodsky A, Sabapathy R, Pershad A.
    Indian Heart J; 2008 Jul 10; 60(3):195-9. PubMed ID: 19240306
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous coronary intervention with stent implantation versus coronary artery bypass surgery for treatment of left main coronary artery disease: is it time to change guidelines?
    Park SJ, Park DW.
    Circ Cardiovasc Interv; 2009 Feb 10; 2(1):59-68. PubMed ID: 20031694
    [Abstract] [Full Text] [Related]

  • 9. Revascularization of left anterior descending artery with drug-eluting stents: comparison with minimally invasive direct coronary artery bypass surgery.
    Ben-Gal Y, Mohr R, Braunstein R, Finkelstein A, Hansson N, Hendler A, Moshkovitz Y, Uretzky G.
    Ann Thorac Surg; 2006 Dec 10; 82(6):2067-71. PubMed ID: 17126111
    [Abstract] [Full Text] [Related]

  • 10. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr 10; 18(100):70-4. PubMed ID: 19585727
    [Abstract] [Full Text] [Related]

  • 11. Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry.
    Vaquerizo B, Lefèvre T, Darremont O, Silvestri M, Louvard Y, Leymarie JL, Garot P, Routledge H, de Marco F, Unterseeh T, Zwahlen M, Morice MC.
    Circulation; 2009 May 05; 119(17):2349-56. PubMed ID: 19380624
    [Abstract] [Full Text] [Related]

  • 12. Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis.
    Palmerini T, Marzocchi A, Marrozzini C, Reggiani LB, Savini C, Marinelli G, Di Bartolomeo R, Branzi A.
    Eur J Cardiothorac Surg; 2007 Apr 05; 31(4):685-90. PubMed ID: 17236785
    [Abstract] [Full Text] [Related]

  • 13. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis.
    Thiele H, Neumann-Schniedewind P, Jacobs S, Boudriot E, Walther T, Mohr FW, Schuler G, Falk V.
    J Am Coll Cardiol; 2009 Jun 23; 53(25):2324-31. PubMed ID: 19539141
    [Abstract] [Full Text] [Related]

  • 14. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
    Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jüni P, Pfisterer ME, Meier B, Kastrati A.
    J Am Coll Cardiol; 2007 Oct 02; 50(14):1373-80. PubMed ID: 17903638
    [Abstract] [Full Text] [Related]

  • 15. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S, Herdeg C.
    Herz; 2008 Apr 02; 33(3):196-205. PubMed ID: 18568314
    [Abstract] [Full Text] [Related]

  • 16. Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program.
    Lasala JM, Cox DA, Morris DL, Breall JA, Mahoney PD, Horwitz PA, Shaw D, Hood KL, Mandinov L, Dawkins KD.
    Am J Cardiol; 2009 Jun 15; 103(12):1663-71. PubMed ID: 19539073
    [Abstract] [Full Text] [Related]

  • 17. 10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial.
    Goy JJ, Kaufmann U, Hurni M, Cook S, Versaci F, Ruchat P, Bertel O, Pieper M, Meier B, Chiarello L, Eeckhout E, SIMA Investigators.
    J Am Coll Cardiol; 2008 Sep 02; 52(10):815-7. PubMed ID: 18755343
    [Abstract] [Full Text] [Related]

  • 18. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

  • 19. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA, Mehilli J, Iijima R, Schulz S, Pache J, Seyfarth M, Schömig A, Kastrati A.
    Eur Heart J; 2009 Apr 10; 30(8):923-31. PubMed ID: 19240066
    [Abstract] [Full Text] [Related]

  • 20. [Long-term follow-up use of "cypher" sirolimus-eluting stents in patients with coronary heart disease after coronary artery bypass grafting with occlusive lesions of the coronary artery].
    Savchenko AP, Akchurin RS, Rudenko BA, Shiriaev AA, Cherkavskaia OV, Kozlov GV.
    Vestn Rentgenol Radiol; 2010 Apr 10; (4):4-12. PubMed ID: 22187903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.